{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:06:30Z","timestamp":1753877190323,"version":"3.41.2"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pancreatic neuroendocrine neoplasms are currently thought to originate from distinct progenitor cells that cannot differentiate into each other. We present the first reported case of a combined pancreatic neuroendocrine tumour and neuroendocrine carcinoma in a 58-year-old man who was investigated for abdominal pain and constipation. Imaging revealed a large left upper quadrant mass infiltrating the pancreatic body and tail, splenic hilum, and posterior stomach wall, with five hepatic metastases. This was treated with neoadjuvant and adjuvant chemotherapy, debulking surgery, and lutetium-177-DOTATATE peptide receptor radionuclide therapy. This case emphasises the importance of molecular imaging, meticulous microscopic examination, and multidisciplinary discussion for accurate diagnoses, improved prognostication, and efficacious treatment.<\/jats:p>","DOI":"10.1093\/jscr\/rjae746","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T10:44:53Z","timestamp":1734173093000},"source":"Crossref","is-referenced-by-count":0,"title":["The first case of combined pancreatic neuroendocrine tumour and neuroendocrine carcinoma"],"prefix":"10.1093","volume":"2024","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0042-3655","authenticated-orcid":false,"given":"Tegan","family":"Lun","sequence":"first","affiliation":[{"name":"Department of Surgery, Townsville University Hospital , Townsville, 4814, QLD ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Rosty","sequence":"additional","affiliation":[{"name":"Envoi Specialist Pathologists , Brisbane, 4059, QLD ,","place":["Australia"]},{"name":"The University of Queensland , Brisbane, 4072, QLD ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranavan","family":"Palamuthusingam","sequence":"additional","affiliation":[{"name":"Department of Surgery, Royal Brisbane and Women\u2019s Hospital , Brisbane, 4006, QLD ,","place":["Australia"]},{"name":"Department of Surgery, The Wesley Hospital , Brisbane, 4066, QLD ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"volume-title":"WHO Classification of Tumours of Endocrine Organs. 4th ed.","year":"2017","author":"Lloyd","key":"2024121410444480100_ref1"},{"volume-title":"AJCC Cancer Staging Manual","year":"2018","key":"2024121410444480100_ref2"},{"key":"2024121410444480100_ref3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s42003-020-01479-y","article-title":"Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression","volume":"3","author":"Di Domenico","year":"2020","journal-title":"Commun Biol"},{"key":"2024121410444480100_ref4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13073-022-01018-w","article-title":"DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors","volume":"14","author":"Simon","year":"2022","journal-title":"Genome Med"},{"key":"2024121410444480100_ref5","doi-asserted-by":"publisher","first-page":"2340389","DOI":"10.1155\/2018\/2340389","article-title":"Clinical and prognostic value of PET\/CT imaging with combination of (68)Ga-DOTATATE and (18)F-FDG in gastroenteropancreatic neuroendocrine neoplasms","volume":"2018","author":"Zhang","year":"2018","journal-title":"Contrast Media Mol Imaging"},{"key":"2024121410444480100_ref6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.radonc.2019.09.003","article-title":"(68)Ga-DOTATATE PET\/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours","volume":"141","author":"Sharma","year":"2019","journal-title":"Radiother Oncol"},{"key":"2024121410444480100_ref7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00259-013-2369-z","article-title":"Role of 18FDG PET\/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours","volume":"40","author":"Severi","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024121410444480100_ref8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann Oncol"},{"key":"2024121410444480100_ref9","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1002\/cam4.2431","article-title":"Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: a SEER-based analysis","volume":"8","author":"Zheng","year":"2019","journal-title":"Cancer Med"},{"key":"2024121410444480100_ref10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/MPA.0b013e3181ebb168","article-title":"NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas","volume":"39","author":"Kulke","year":"2010","journal-title":"Pancreas"},{"key":"2024121410444480100_ref11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000497336","article-title":"Carboplatin in combination with oral or intravenous etoposide for extra-pulmonary, poorly-differentiated neuroendocrine carcinomas","volume":"109","author":"Frizziero","year":"2019","journal-title":"Neuroendocrinology"},{"key":"2024121410444480100_ref12","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1200\/JCO.2011.37.2151","article-title":"Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers","volume":"30","author":"Villard","year":"2012","journal-title":"J Clin Oncol"},{"key":"2024121410444480100_ref13","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1200\/JCO.2018.78.5865","article-title":"Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with (177)Lu-Dotatate in the phase III NETTER-1 trial","volume":"36","author":"Strosberg","year":"2018","journal-title":"J Clin Oncol"},{"key":"2024121410444480100_ref14","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1007\/s00259-022-05786-w","article-title":"Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based (177)Lu-DOTATATE treatment of NET patients","volume":"49","author":"Sundlov","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024121410444480100_ref15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2967\/jnumed.117.189712","article-title":"Persistent hematologic dysfunction after peptide receptor radionuclide therapy with (177)Lu-DOTATATE: incidence, course, and predicting factors in patients with gastroenteropancreatic neuroendocrine tumors","volume":"59","author":"Bergsma","year":"2018","journal-title":"J Nucl Med"}],"container-title":["Journal of Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jscr\/article-pdf\/2024\/12\/rjae746\/60928149\/rjae746.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jscr\/article-pdf\/2024\/12\/rjae746\/60928149\/rjae746.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T10:44:55Z","timestamp":1734173095000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jscr\/article\/doi\/10.1093\/jscr\/rjae746\/7914458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jscr\/rjae746","relation":{},"ISSN":["2042-8812"],"issn-type":[{"type":"electronic","value":"2042-8812"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,12,1]]},"article-number":"rjae746"}}